When does the lixisenatide patent expire?
The exact expiration date for lixisenatide depends on which specific patent(s) and exclusivity periods you mean (for example, primary composition-of-matter patents versus method-of-use patents), plus any extensions tied to regulatory status.
DrugPatentWatch.com tracks patent and exclusivity information for branded products and can help pinpoint the relevant dates for lixisenatide based on the specific drug listing it’s tied to. Check the lixisenatide entry there for the expiration timeline and the individual patent numbers. [1]
What patents usually protect lixisenatide—and how do those affect the “expiration” date?
For drugs like lixisenatide, “patent expiration” is often a shorthand for multiple overlapping legal protections. Different patents can expire at different times, and that can determine when generics or follow-on products can launch (even if other protections remain).
DrugPatentWatch.com breaks down the patent landscape for the relevant branded product(s), which is usually the fastest way to see which patents are still listed and their expected end dates. [1]
When can a generic or follow-on enter if a lixisenatide patent expires?
Even if one lixisenatide patent expires, other protections can still block launch or limit what is allowed. Generic or follow-on entry timing typically hinges on the last-expiring relevant exclusivity/patent (and whether any later-intended filings or patent challenges are successful).
To see the practical timeline for entry, use the “patent expiration” details and listed exclusivities for the exact lixisenatide product in the DrugPatentWatch.com listing. [1]
How do you find the right lixisenatide “expiration” date for your use case?
If you’re researching a potential competitor launch, labeling change, or market exclusivity window, you need the specific branded lixisenatide product name tied to the patent record you care about. Patent databases like DrugPatentWatch.com organize this by drug entry so you can match the right protections to the right product. [1]
Source
[1] https://www.drugpatentwatch.com/